Circadian Time Restricted Eating
The goal of this study is to learn more about how the time in which participants consume their meals relative to their personalized circadian rhythm influences their overall cardiometabolic health and weight. The investigators are hoping to discover if a circadian-based time restricted eating intervention will improve cardiometabolic health and decrease weight. The protocol is a 46 day prospective cohort study that includes both field and in-laboratory data collection in overweight and obese individuals.
Conditions:
🦠 Circadian Rhythm 🦠 Cardiometabolic Health 🦠 Weight Loss 🦠 Cardiovascular Health 🦠 Time Restricted Feeding
🗓️ Study Start (Actual) 1 April 2023
🗓️ Primary Completion (Estimated) 1 December 2024
✅ Study Completion (Estimated) 1 December 2024
👥 Enrollment (Estimated) 10
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Portland, Oregon, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. Healthy, overweight or obese individuals.

    Exclusion Criteria:

    • 1. Participants must have a body mass index (BMI) greater than or equal to 27 kilograms per meter squared.
    • 2. No history of drug or alcohol dependency. Must be current non-smokers, and are required to have a history of less than 5 pack years of smoking.
    • 3. No history of working irregular day and night hours, regular night work, or rotating shift work for the 1 year prior to the study. In addition to this, individuals must not have traveled across more than 1 time zone during the 3 months prior to the study.
    • 4. Chronobiologic and sleep disorders.
    • 5. Diseases of the cardiovascular system.
    • 6. Hypertension. Individuals will be allowed to be normotensive (resting systolic blood pressure of \<140/90 mmHg, measured on more than one occasion) or uncomplicated stage 1 hypertension (systolic BP between 140 and 159 mmHg or a diastolic BP between 90 and 99 mmHg).
    • 7. Disorders of the respiratory system.
    • 8. Pre-diabetes/Diabetes. For participants who have a fasting blood glucose level that is greater than or equal to 100 mg/dL, the investigators will measure hemoglobin A1c to exclude for diabetes (HbA1c\>5.7%).
    • 9. Disorders of the kidney and urinary tract.
    • 10. Infectious diseases.
    • 11. Disorders of the gastrointestinal system.
    • 12. Disorders of the immune system.
    • 13. Disorders of the hematopoietic system.
    • 14. Neoplastic diseases.
    • 15. Endocrine and metabolic diseases.
    • 16. Neurologic disorders.
    • 17. Must not be participating in another research study that would influence their safe participation in the study.
Ages Eligible for Study: 18 Years to 40 Years (ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 16 November 2022
  • First Submitted that Met QC Criteria 16 November 2022
  • First Posted 28 November 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 2 April 2024
  • Last Update Posted 3 April 2024
  • Last Verified April 2024